Maternal smoking during pregnancy increases the risk of gut microbiome-associated childhood overweight and obesityOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study asked whether the infant gut microbiome links maternal smoking during pregnancy to childhood overweight and obesity. It combined smoking data, infant stool microbiome profiles, fecal metabolites and childhood weight outcomes. Stool was collected at about 3 and 12 months and sequenced across the 16S rRNA V4 region. Metabolites were quantified by magnetic resonance spectroscopy. Weight was measured at ages 1 and 3 years. Mediation analysis tested whether microbial features carried the smoking effect, adjusting for many confounders.
Who was studied?
The cohort was 1,592 infants from the Canadian Healthy Infant Longitudinal Development (CHILD) general-population birth cohort. All had complete smoking, weight and 3-month microbiome data. BMI data were available for 1,441 children at age 3, and 1,389 had 12-month microbiome data. Most mothers never smoked (72.3%) or quit before pregnancy (19.3%). Self-reported smoking matched infant urinary nicotine metabolites measured at 3 months, confirming exposure.
What were the most important findings?
Children exposed to maternal smoking in pregnancy had higher BMI z-scores at age 3 (beta 0.28) and higher odds of being at-risk or overweight (odds ratio 1.78). Quitting or cutting cigarettes during pregnancy did not remove the risk. Maternal smoking raised infant Firmicutes abundance and diversity, especially Clostridia members like Lachnospiraceae and Oscillospiraceae. Firmicutes Chao1 richness and Faith's phylogenetic diversity mediated 12 to 25% of the smoking effect on BMI. Smoke-exposed infants of normal-weight mothers had elevated fecal butyrate and butyrate-producing pathways, and butyrate correlated positively with BMI. Exclusive breastfeeding to 3 months appeared to blunt the risk.
What are the greatest implications of this study?
The findings point to the infant gut microbiome as a mediator between prenatal smoke exposure and childhood overweight, with excess butyrate production a plausible obesogenic route. This reframes butyrate, usually seen as beneficial, as potentially harmful in early life. Because quitting during pregnancy did not lower risk, the results support quitting before conception. Early exclusive breastfeeding may partly offset the risk, offering an intervention window. The study is observational with no maternal microbiome samples, so causation remains unproven and needs experimental confirmation.